Utah Lawmakers Unanimously Approve Bill To Allow Psilocybin And MDMA Treatment At Hospitals, Sending It To The Governor
Top Federal Drug Agency Cites Marijuana And Psychedelics Research Efforts To Justify Congressional Funding
Virginia Lawmakers Don’t Expect Governor To Sign Marijuana Sales Bill
Maryland House Approves Bill To Create Psychedelics Task Force To Study Regulated Therapeutic Access
Massachusetts Governor To Pardon Hundreds Of Thousands With Marijuana Convictions
Psychedelic Use Linked To ‘Lower Rates Of Psychotic Symptoms’ In Adolescents, Study Published By American Medical Association Finds
Marijuana Can Help Increase Orgasm Frequency And Satisfaction For Women, Study Finds
Teen Use Of Delta-8 THC Is Higher In States Without Legal Marijuana, New Study Published By American Medical Association Finds
New USDA Hemp ‘Roadmap’ Highlights Research Needs And Proposes Public-Private Consortium To Streamline Studies
CBD May Ease Menstrual-Related Symptoms Like Irritability And Stress, Study Finds
Marijuana Rolling Paper Company Seeks Content Creator To ‘Get Paid To Smoke Weed’ For $70,420 Salary
Nevada’s First Marijuana Consumption Lounge Officially Opens, With Top Lawmaker Hitting A Joint At 4:20
Rapper Killer Mike Suggests Giving Black People Control Over Marijuana Industry As A Form Of Reparations
Brooklyn Nets And New York Liberty Become First NBA And WNBA Teams To Partner With CBD Company
UFC Warns Fighters To Stop Using Marijuana ‘Immediately’ So They Aren’t Punished Under California Athletics Rules
Massachusetts Marijuana Sales Pass $7 Billion Mark As Prices Hit Record Low
U.S. Company Offers Free Psychedelics Training Services To Ukraine Health Professionals To Treat Trauma From War With Russia
New Mexico Officials Celebrate Marijuana Milestone As Sales Cross $1 Billion Mark Since Recreational Market Launched
Missouri’s Marijuana Market Tallied More Than $1.4 Billion During First Full Year Of Adult-Use Sales
Missouri Marijuana Company Argues That Workers Are Not Allowed To Unionize Due To Federal Law
Massachusetts Governor To Pardon Hundreds Of Thousands With Marijuana Convictions
Hawaii Senate Panel Guts House-Passed Marijuana Expungements Bill, Limiting It To A Single-County Pilot Program
‘Rats Are Eating Our Marijuana,’ New Orleans Police Superintendent Tells City Council, Adding That ‘They’re All High’
Arizona House Panel Advances Bill To Legalize Psilocybin Service Centers That Has Already Passed The Full Senate
New Hampshire GOP Governor Reaffirms He’d Sign Marijuana Legalization Bill With State-Run Model Despite Personal Reservations
Feds pressed on cannabis research delays (Newsletter: March 13, 2024)
DEA cannabis rescheduling turmoil (Newsletter: March 12, 2024)
Virginia governor vetoes cannabis bill (Newsletter: March 11, 2024)
Biden touts cannabis moves in State of the Union (Newsletter: March 8, 2024)
Cannabis banking on tap for passage by Nov, Schumer says (Newsletter: March 7, 2024)
Published
on
By
Bipartisan Washington State lawmakers prefiled a Senate bill last week that would allow nonprofits to provide psilocybin services to clients 21 and older so long as the organizations “have an explicit goal of promoting wellness for and assisting military veterans or first responders.”
Sponsored by Sens. Jesse Salomon (D) and Ann Rivers (R), SB 5977 appears to build on the state’s limited psychedelics pilot program signed into law last year, which is also aimed at serving veterans and first responders, including law enforcement, firefighters, coroners, medical examiners and emergency medical personnel.
The new limited measure would require nonprofits to use psychedelics facilitators licensed “by the state of Oregon, or another state with with a state facilitator license and licensure requirements that meet or exceed the Oregon state requirements with regard to required training, background checks, and licensing examination.”
Participants, the bill says explicitly, must be “21 years of age or older and a military veteran or first responder.”
Certain safety precautions would also need to be taken under the bill. Providers would need to develop transportation plans for each participant, for example, and “make reasonable efforts to prevent participants from operating a motor vehicle at the conclusion of an administration session.”
Notably, if a client’s failure to follow a transportation plan creates a safety issue, the legislation says, “the nonprofit must make reasonable efforts to resolve the safety issue.”
Facilitators would also need to develop a screening process to confirm that participants don’t have medical or psychiatric concerns that might interact negatively with psychedelics, which would include questions about current medications, current and past allergies, whether the participant is pregnant or breast feeding, a participant’s mental health history, a participant’s risk of harming themself or other, whether a participant has had a traumatic brain injury and any other language, mobility or medical assistance issues.
While providers could generally not charge participants for psilocybin or psilocybin services under the bill, they “may charge a participant the at cost rate for the screening” process required as part of therapy.
Certain people would also be barred from accessing psilocybin services, including those who have taken lithium within 30 days, are having thoughts of hurting themselves or others or have a variety of health conditions, including schizophrenia, active psychosis, bipolar I disorder, uncontrolled high blood pressure, heart disease or heart arrhythmia.
Others, including those on antidepressants or in treatment for mental health conditions “must be encouraged to consult a medical, clinical, or other health care provider regarding the risk of consuming psilocybin.”
Certain other preexisting conditions, such as antisocial personality disorder or borderline personality disorder, carry additional requirements. People with those personality disorders, for example, would need to attend “a minimum of six integration sessions and the nonprofit organization must provide a referral to a licensed mental health provider for consultation postadministration.”
All facilitated psilocybin use would need to include at least three preparation sessions, one administration session and at least three post-administration integration sessions.
The legislation is another attempt at psychedelics reform from Salomon, one of the lawmakers who previously sponsored SB 5263, which created the state’s limited psilocybin pilot program. That measure began the session as a much broader legalization proposal and would have allowed adults 21 and older to lawfully use psilocybin under the care of trained, state-licensed facilitators—similar to the system approved by Oregon voters in 2020.
—
Marijuana Moment is tracking more than 900 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
The new bill comes as grassroots efforts across the state seek to decriminalize psychedelics at the local level by deprioritizing enforcement of state laws against the substances. Organizers in at least six Washington cities are working to enact the reform, which they also see as a way to build support for change at the state level.
Another bill recently introduced as the state’s legislative session kicks off this month would roll back recently enacted protections for job applicants who use marijuana. Specifically, the proposal would undo the anti-discrimination protections for people seeking to work in the drug treatment industry.
A national poll published last year found that a majority of U.S. voters support legal access to psychedelics therapy and back federally decriminalizing substances like psilocybin and MDMA.
A 2022 analysis published in an American Medical Association journal, meanwhile, concluded based on statistical modeling of policy trends that a majority of states will legalize psychedelics by 2037.
Separately, a Washington state doctor is challenging the Drug Enforcement Administration in federal court in an effort to be able to provide psilocybin-assisted end-of-life care to patients with cancer.
Study Finds Most Cancer Survivors Who Used Marijuana Reported ‘Great Degree Of Symptomatic Improvement’
Cleveland Mayor Says He’s Open To Taking Marijuana Gummy, But Argues State Needs To ‘Get It Together’ To Provide Legal Sales First
Hawaii Attorney General Sends Marijuana Legalization Bill To Lawmakers, But Says She ‘Does Not Support’ It
Ben Adlin, a senior editor at Marijuana Moment, has been covering cannabis and other drug policy issues professionally since 2011. He was previously a senior news editor at Leafly, an associate editor at the Los Angeles Daily Journal and a Coro Fellow in Public Affairs. He lives in Washington State.
Utah Lawmakers Unanimously Approve Bill To Allow Psilocybin And MDMA Treatment At Hospitals, Sending It To The Governor
Top Federal Drug Agency Cites Marijuana And Psychedelics Research Efforts To Justify Congressional Funding
Virginia Lawmakers Don’t Expect Governor To Sign Marijuana Sales Bill
Maryland House Approves Bill To Create Psychedelics Task Force To Study Regulated Therapeutic Access
Psychedelic Use Linked To ‘Lower Rates Of Psychotic Symptoms’ In Adolescents, Study Published By American Medical Association Finds
Massachusetts Governor To Pardon Hundreds Of Thousands With Marijuana Convictions
All the cannabis news you need, all in one place. Copyright © 2017-2024 Marijuana Moment LLC ® and Tom Angell
New Bipartisan Washington Bill Would Legalize Psilocybin Therapy For Veterans And First Responders – Marijuana Moment
